On this page:Overview Publications Researchers Institutions Open access

ScholarIQanswers from OpenAlex

Klinik für Frauenheilkunde

InstitutionResearch output, impact & collaborations

Klinik für Frauenheilkunde is a institution indexed in ScholarIQ from OpenAlex.

What is known about Klinik für Frauenheilkunde?

ScholarIQrecord summary

Klinik für Frauenheilkunde is a research organisation in Freiburg, DE. OpenAlex records 10,425 works and 140,234 citations for it. 3,857 researchers list it as their most recent affiliation.

How many works does Klinik für Frauenheilkunde have?

ScholarIQindexed works

Klinik für Frauenheilkunde has 10,425 works in the ScholarIQ index. The count is the OpenAlex total, not the number of papers listed on this page.

See the works listed for Klinik für Frauenheilkunde →

How many citations does Klinik für Frauenheilkunde have?

ScholarIQcitation count

Klinik für Frauenheilkunde has 140,234 citations in the OpenAlex counts ScholarIQ stores.

See the listed works for Klinik für Frauenheilkunde →

How many researchers are at Klinik für Frauenheilkunde?

ScholarIQresearcher count

Klinik für Frauenheilkunde has 3,857 researchers in the ScholarIQ index.

See the researchers listed on this page →

What is the average h-index at Klinik für Frauenheilkunde?

ScholarIQavg h-index

Klinik für Frauenheilkunde has an average h-index of 27.5 in OpenAlex.

Open the OpenAlex record →

What is the ROR of Klinik für Frauenheilkunde?

ScholarIQror

The ROR for Klinik für Frauenheilkunde is on the source record.

Open the ROR →

What is the OpenAlex record for Klinik für Frauenheilkunde?

ScholarIQopenalex

The OpenAlex for Klinik für Frauenheilkunde is on the source record.

Open the OpenAlex →

Who are the most-cited researchers behind Klinik für Frauenheilkunde?

ScholarIQtop researchers by citations

Achim Rody · Breast Cancer Treatment Studies

569 works9,731 citations

Katrina Kraft · Pregnancy and preeclampsia studies

63 works376 citations

What are the most-cited papers on Klinik für Frauenheilkunde?

ScholarIQmost cited works

A CONTROLLED TRIAL OF ARTHROSCOPIC SURGERY FOR OSTEOARTHRITIS OF THE KNEE

J. B Ruce, K Imberly, Ancy J. P Etersen, T Erri J. M Enke, Achim Rody, D Avid H. K Uykendall, J Ohn, C Arol M. A Shton, Elda P. W Ray

20021,091 Citations

A New Molecular Predictor of Distant Recurrence in ER-Positive, HER2-Negative Breast Cancer Adds Independent Information to Conventional Clinical Risk Factors

Martin Filipits, Margaretha Rudas, R. Jakesz, Peter Dubsky, Florian Fitzal, Christian F. Singer, Otto Dietze, Richard Greil, Andrea Jelen, P. Sevelda, Christa Freibauer, Volkmar Müller, F. Jänicke, Marcus Schmidt, H. Kölbl, Achim Rody, Manfred Kaufmann, Werner Schroth, Hiltrud Brauch, Matthias Schwab, Péter Fritz, Karsten E. Weber, Inke Sabine Feder, Guido Hennig, Ralf Kronenwett, Mathias Gehrmann, Michael Gnant

Clinical Cancer Research. 2011732 CitationsOPEN ACCESS

T-cell metagene predicts a favorable prognosis in estrogen receptor-negative and HER2-positive breast cancers

Achim Rody, Uwe Holtrich, L. Pusztai, Cornelia Liedtke, R. Gaetje, Eugen Ruckhaeberle, Christine Solbach, Lars Hanker, A. Ahr, Dirk Metzler, Knut Engels, Thomas Karn, Manfred Kaufmann

Breast Cancer Research. 2009484 CitationsOPEN ACCESS

A clinically relevant gene signature in triple negative and basal-like breast cancer

Achim Rody, Thomas Karn, Cornelia Liedtke, Lajos Pusztai, Eugen Ruckhaeberle, Lars Hanker, R. Gaetje, Christine Solbach, A. Ahr, Dirk Metzler, Marcus Schmidt, Volkmar Müller, Uwe Holtrich, Manfred Kaufmann

Breast Cancer Research. 2011337 CitationsOPEN ACCESS

Microarray analysis of altered sphingolipid metabolism reveals prognostic significance of sphingosine kinase 1 in breast cancer

Eugen Ruckhäberle, Achim Rody, Knut Engels, R. Gaetje, Gϋnter von Minckwitz, Susanne Schiffmann, Sabine Grösch, Gerd Geißlinger, Uwe Holtrich, Thomas Karn, Manfred Kaufmann

Breast Cancer Research and Treatment. 2007297 Citations

How much of the research on Klinik für Frauenheilkunde is open access?

ScholarIQopen access share

67%OPEN ACCESS

Gold

25%

Green

Hybrid

Bronze

33%

Closed

33%